Patent · US Active

Benzimidazolium compounds and salts of benzimidazolium compounds for nucleic acid amplification

US7781165B2 · kind B2 · utility

4Cited by

12References

6Claims

0Family size

Assignee

Roche Diagnostics Operations, Inc. · US

Inventors

Christian Birkner · Irlbach, DE
Frank Bergmann · Iffeldorf, DE
Herbert von der Eltz · Spaichingen, DE

Key dates

Filing date	Oct 16, 2006
Grant date	Aug 24, 2010
Priority date	—
Expiry date	Oct 11, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q1/6844
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention is directed to the use of a benzimidazolium compound comprising a side chain at at least one of its N-residues, said chain being either a Cn-alkyl or a substituted Cn-alkyl, characterized in that preferably n is ≧3, as an additive for a nucleic acid amplification reaction.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.